V Validation Of The Association Of Recist 1.0 Changes With Survival In Men With Metastatic Castration Resistant Prostate Cancer (Mcrpc) Treated On Swog Study S0421.

Gregory R. Pond,Guru Sonpavde,Melissa Plets,Maha Hussain,Primo N. Lara,Amir Goldkorn,Mark Garzotto,Philip C. Mack,Celestia S. Higano,Nicholas J. Vogelzang,Ian M. Thompson,Przemyslaw Twardowski,Peter Van Veldhuizen,Neeraj Agarwal,Michael A. Carducci,Paul Monk,David I. Quinn

JOURNAL OF CLINICAL ONCOLOGY（2016）

引用 0|浏览7

暂无评分

摘要

5079Background: Prostate specific antigen (PSA) and bone scan changes are often used as components of primary endpoints in phase II trials of mCRPC. However, they do not reliably capture drug activ...

查看译文

关键词

prostate cancer,mcrpc,recist,castration-resistant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要